| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 656206 | Discorhabdin I | 0.0105972823829604 | -0.24316125 |
| NSC 673187 | - | 0.0105972823829604 | -0.18000935 |
| NSC 680094 | 17-(O-Diethylaminoethyl)oximino-3-methoxy-1,3,5(10)- estratriene hydrochloride | 0.0105972823829604 | -0.23250539 |
| NSC 684481 | 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 2-(3-chloro- phenyl)-5,6-dihydro-4-phenyl- | 0.0105972823829604 | 0.36403187 |
| NSC 707904 | Null | 0.0105972823829604 | 0.0013946891 |
| NSC 708559 | Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) | 0.0105972823829604 | -0.41034816 |
| NSC 715778 | Null | 0.0105972823829604 | -0.14124747 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0105972823829604 | 0.046991379 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0105972823829604 | -0.099380881 |
| NSC 733504 | Everolimus | 0.0105972823829604 | 0.42590698 |